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Chronic ginseng treatments have been purported to improve cardiac performance. How-
ever reports of acute administration of ginseng on cardiovascular function remain controver-
sial and potential mechanisms are not clear. In this study, we examined the effects of acute
North American ginseng (Panax quinquefolius) administration on rat cardiac contractile
function by using electrocardiogram (ECG), non-invasive blood pressure (BP)measurement,
and Langendorff isolated, spontaneously beating, perfused heart measurements (LP).
Eight-week old male Sprague–Dawley rats (n = 8 per group) were gavaged with a single
dose of water-soluble American ginseng at 300 mg/kg body weight. Heart rate (HR) and
BP were measured prior to and at 1 and 24 h after gavaging (ECG and BP). Additional
groups were used for each time point for Langendorff measurements. HR was signiﬁcantly
decreased (ECG: 1 h: 6 ± 0.2%, 24 h: 8 ± 0.3%; BP: 1 h: 8.8 ± 0.2%, 24 h: 13 ± 0.4%
and LP: 1 h: 22 ± 0.4%, 24 h: 19 ± 0.4%) in rats treated with water-soluble ginseng
compared with pre or control measures. An initial marked decrease in left ventricular
developed pressure was observed in LP hearts but BP changes were not observed in
BP group. A direct inhibitory effect of North American ginseng was observed on cardiac
contractile function in LP rats and on ﬂuorescence measurement of intracellular calcium
transient in freshly isolated cardiac myocytes when exposed to ginseng (1 and 10 μg/ml).
Collectively these data present evidence of depressed cardiac contractile function by acute
administration of North American ginseng in rat. This acute reduction in cardiac contractile
function appears to be intrinsic to the myocardium.
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INTRODUCTION
Ginseng is a popular herbal remedy widely used to improve car-
diac health and circulation. Chronic Panax ginseng treatment
has been shown to improve cardiac performance, as reﬂected by
improvements in isolated heart contractility and mitochondrial
oxidation (Toh, 1994; Chen, 1996), as well as to increase protection
against myocardial ischemia/reperfusion damage by enhancing
NO release (Chen, 1996).
In human research, the effects of different herbal compounds,
containing ginseng products, on the cardiovascular system are
equivocal. On one hand, supplements containing ginseng have
been found to decrease heart rate (HR), suggesting that ginseng
may affect the autonomic nervous system (Kiesewetter et al., 1992;
Zheng and Moritani, 2008). On the other hand, the effects of gin-
seng on BP remain controversial. For instance, increases (Siegel,
1980), decreases (Kiesewetter et al., 1992; Han et al., 1998), and
no change (Stavro et al., 2005, 2006) in BP have been reported.
The reasons for these discrepancies might be related to the postu-
lated biphasic actions of ginsenosides on BP, with initial decreases,
followed by increases (Kaku et al., 1975; Chen et al., 1984). Addi-
tionally, the effects of chronic versus acute supplementation with
ginseng have to be considered. For example, although chronic
ginseng treatment appears to improve cardiac performance, the
effects of acute administration of ginseng on cardiovascular func-
tion remains controversial (Bahrke and Morgan, 1994; Gillis,
1997) as enhanced (Toh, 1994), little change or depressed cardiac
function (Jin and Liu, 1994; Jin, 1996), have been reported.
Another factor modulating the effects of ginseng is the type
of ginseng used during the intervention. It has been recognized
that North American ginseng (P. quinquefolius) differs from other
species of ginseng likeAsian ginseng (P. ginseng) in its active ingre-
dients and characteristic biological responses. North American
ginseng has a ginsenoside proﬁle different from that of Asian gin-
seng in terms of total ginsenosides, the ratio of protopanaxadiol
(PPD) to protopanaxatriol (PPT), and other marker ginsenosides
(Qi et al., 2011). For example, ginsenosides Rb1 and Re appear
to be most abundant in North American ginseng, whereas Asian
ginseng (Chinese/Korean Ginseng) is enriched in Rg1 and Rg2
ginsenosides. Traditional Chinese medicine asserts that North
American ginseng promotes yin in the body while Asian ginseng
promotes yang. Despite these knowndifferences between these two
species of ginseng, little is known about the effects of NorthAmer-
ican ginseng on cardiovascular responses, given that the majority
of research in this area have usedAsian ginseng as the intervention.
Therefore, the purpose of this study was to examine the effect
of acute administration of NorthAmerican, water-soluble ginseng
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on rat cardiac contractile function at 1 and 24 h post-ginseng
treatment and to explore potential direct effects upon the heart.
We hypothesized that acute administration of North American
ginseng would have no effect on the contractile performance of
the myocardium.
MATERIALS AND METHODS
PREPARATION OF GINSENG ROOT EXTRACT
Four year oldNorthAmerican ginseng roots collected in 2007 from
ﬁve different farms in ON, Canada were provided by the Ontario
Ginseng Growers Association. Dried ginseng root samples were
shipped to Naturex Inc. (South Hackensack, NJ, USA) for extrac-
tion. In order to reduce variability ﬁnal ginseng extracts from
each farm were prepared individually and were then combined
to produce composite extracts at the Ontario Ginseng Innovation
and Research Consortium central facility (London, ON, Canada)
which were used for the present study. A detailed methodology
for aqueous extraction has been previously published elsewhere
(Azike et al., 2011). Brieﬂy, dried ginseng root samples were
ground and soaked in water at 40◦C for a duration of 5 h. The
resultant solutions were ﬁltered and excess solvent was removed
by a rotary evaporator under vacuum at 45◦C. The ginseng pools
were combined and concentrated to yield a concentration of 60%.
The concentrates were lyophilized with a freeze drier at –50◦C
under reduced pressure to produce ginseng aqueous extract in
powder form.
ANIMALS
All animals were cared for according to the Guiding Principle in
the Care and Use of Animals. All experiments were approved by
the University of Western Ontario council on animal care com-
mittee. Seventy-seven, adult (8-week-old) male Sprague–Dawley
rats (Charles River Laboratories International Inc. Sherbrooke,
QC, Canada) were used in the study. The animals were acclimated
to a 12-hour day-night cycle, housed in rodent cages, and fed
standard rodent chow. Rats were gavaged with water (control) or
water-soluble American ginseng extract (300mg/kg body weight).
According to the NHPD Monograph of Health Canada1, the rec-
ommendedmaximumdaily dose of American ginseng for humans
is 12 gm of dry roots; and this is equivalent to 170 mg/kg of body
weight. After taking consideration of the 40–50% yield of extract
from ginseng root according to the our processing protocol, and
the extrapolation factor of ﬁve to one used in translating human
to rodent dosage of therapeutics (because of species-difference in
metabolic rate), our current dosage used is relevant to what is
consumed in humans. HR and developed pressure were measured
1 and 24 h after gavaging. For each of the electrocardiographic
(ECG) and non-invasive measurement of BP experiments (see
below), 24 animals were used. They were divided into a) control
animals (n = 8) measured at both 1 and 24 h post-gavage with
water and, b) experimental animals (n = 8) assessed at 1 and 24 h
post-gavage with ginseng. Twenty-four animals were used in the
Langendorff (LP) experiment (n = 6 each for 1 h control, 1 h
ginseng, 24 h control, and 24 h ginseng groups) and ﬁve in the
isolated myocyte experiment.
1http://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.do?id = 29&lang = eng
Electrocardiography
Three-lead ECGs were recorded while rats were under light anes-
thesia (isoﬂurane – 2% in 99% O2). All animals had their ECG’s
recorded for only 10 min to avoid the side effects of prolonged
anesthesia. Total time per animal for the complete procedure was
no longer than 15 min. For this study, subcutaneous needle elec-
trodes were used for ECG, as described previously (Tipton and
Taylor, 1965). The ECG signal was recorded using a Honeywell
ECG ampliﬁer (Honeywell Electronics for Medicine, Edmonton,
Canada). The analog electrocardiogram was sampled at 1000 Hz
and recorded using a Powerlab 8/30 Data Acquisition system and
analyzed using Labchart 7.0 pro software (ADInstruments, Col-
orado Springs, Colo, USA). The mean of 10 cycles was taken for
the measurement of PR, QRS, and RR intervals.
NON-INVASIVE MEASUREMENT OF BLOOD PRESSURE
Systolic and diastolic BPs were measured in conscious rats using a
non-invasive computerized tail cuff system (CODA Non-Invasive
BP Monitor, Kent Scientiﬁc Corporation, Torrington, CT, USA).
Rats were conditioned to tail cuff instrumentation for three
days before the experiment to minimize the effects of cuff inﬂa-
tion/deﬂation stress. BP analyses consisted of 15 tail cuff pressure
acquisitions per run. Data for individual animals represent the
average of at least ﬁve high-quality acquisitions. HRs were also
recorded during these measurements.
LANGENDORFF HEART PREPARATION
The rats were killed by decapitation and the hearts were imme-
diately excised and immersed in ice-cold Krebs–Henseleit buffer
producing an immediate cessation of contraction. Then the hearts
were rapidly cannulated for retrograde aortic perfusion by amodi-
ﬁed non-recirculating Langendorff technique (Su and Narayanan,
1993). The perfusion ﬂuid was Krebs–Henseleit buffer (pH 7.4)
consisting of (in mM): 120 NaC1, 4.63 KC1, 1.17 KH2PO4, 20
NaHCO3, 1.25CaC12, 1.20MgCl2, and 8mMglucose as substrate.
The buffer was gassed with a 95%O2/5%CO2 mixture. The entire
perfusion system was maintained at 37◦C using a water-jacketed
condenser attached to a circulator. Unpaced hearts were perfused
at a constant ﬂow rate of 9 ml/min. In a subset of 1 and 24 h con-
trol hearts (n = 4), control data was recorded initially and then
successive doses of ginseng (25 and 250 μg/ml for 3 min each)
were added. Cardiac function was determined under each condi-
tion and hearts were washed out and returned to baseline function
(10–15 min) between these successive ginseng administrations.
To determine left ventricular function, a water-ﬁlled latex bal-
loon was inserted into the left ventricle through the mitral valve.
Left ventricular end-diastolic pressure (LVEDP) was adjusted to
5 mmHg by increasing the balloon volume with a micrometer-
ﬁtted syringe. Left ventricular pressures (LVEDP and developed
pressure) were obtained with a pressure transducer (Statham
Gould P23ID). The rate of pressure development (+dP/dt) and
relaxation (−dP/dt) were obtained electronically using a Power-
lab 8/30 Data Acquisition system and analyzed by Labchart 7.0 pro
software (ADInstruments, Colorado Springs, Colorado, USA).
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ISOLATION OF CARDIAC MYOCYTES
Five additional rats were used for this part of the study. Isolation
of adult rat ventricular myocytes was carried out using a method
described byKilic et al. (2009). In brief, the heart from each rat was
removed and retrogradely perfused with a Ca2+-free buffer. After
5 min of perfusion, the heart was switched to a buffer containing
collagenase (Worthington Biochemical, Lakewood, NJ, USA) and
proteases. At the end of digestion, the heart was removed and
the ventricles were minced into small pieces in stop buffer. The
cell suspension was ﬁltered through a nylon 210 size mesh and
the extracellular Ca2+ concentration was increased in a stepwise
fashion (up to 1 mM). The viability of cardiomyocytes was greater
than 90% of the ﬁnal cell population.
FLUORESCENCE RECORDING OF [Ca2+]i
[Ca2+]i was measured using fura-2 ﬂuorescence from single car-
diacmyocytes as described previously (Weidema et al., 1997). Cells
were loaded by incubation with 0.5μM fura-2 acetoxymethylester
(Molecular Probes) for 30 min at room temperature. The
cells were continuously superfused with Sodium Ringer solu-
tion containing 1 mM CaCl2 and ﬁeld stimulated with bipolar
platinum electrodes, using a pulse duration of 1 ms and a fre-
quency of 0.5 Hz, with voltage set at 60–80 V. Intracellular
calcium ﬂuorescence measurements were made using a dual-
wavelength Deltascan spectroﬂuorimeter [Photon Technology
International (PTI)]. Cells were illuminated by epiﬂuorescence
with alternating 345 and 380 nm light from a Xenon lamp and
a Nikon Fluor 40× objective lens and recorded by photome-
ter. The emission signal was ﬁltered using a 510 nm bandpass
ﬁlter. [Ca2+]i was calculated from the ratio of the ﬂuores-
cence intensities at 345 and 380 nm following correction for
background.
STATISTICAL ANALYSIS
Data are presented as means ± SEM. Statistical signiﬁcance was
assessed with either the Student’s t-test (to compare before and
after ginseng treatment on Langendorff preparations at 25 and
250 μg/ml) or one-way and repeated measures ANOVA, followed
by Tukey post hoc test (all other comparisons). p < 0.05 was taken
as the level of signiﬁcance.
RESULTS
Figure 1 shows ECG data recorded from control rats and rats
treated with water-soluble ginseng (1 and 24 h after gavaging).
There was a group effect for HR so that it was lower in ginseng
treated rats compared with control rats at both 1 and 24 h after
FIGURE 1 | Electrocardiogram data recorded from control animals
and those treated with water-soluble ginseng (n = 8/group; 1 and
24 h after gavaging). (A) Displays typical ECG tracings; (B) Displays
typical HR responses; and (C) Shows that the RR, PR, QRS, and QT
intervals. Data are presented as mean ± SE. *p < 0.05 compared to
control.
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ginseng gavage (p < 0.05; Figure 1A). HR did not differ between
1 and 24 h groups in either the control or the ginseng treated
conditions, indicating no time-dependence (p < 0.05; Figure 1A).
The RR, PR, QRS, and QT interval were consistently prolonged in
ginseng treated rats comparedwith controls (p < 0.05; Figure 1B).
These data are summarized in Table 1.
Non-invasive measurements of HR and BP are depicted in
Figure 2. HR and developed pressure of the heart (removed from
animals treated 1 and 24 h after gavage with ginseng) were also
measured ex vivo via a Langendorff preparation. HR was lower in
ginseng treated groups compared with control rats (1 h control,
424 ± 8 beats per minute (BPM); 1 h ginseng 387 ± 6 BPM;
24 h control: 421 ± 13 BPM, 24 h ginseng, 372 ± 7 BPM,
p < 0.05, Figure 2A). In the ginseng treated group, HR was lower
at 24 h compared to 1 h after gavaging (p < 0.05, Figure 2A).
Systolic and diastolic pressures did not differ between the con-
trol and ginseng treated groups at any time point (p > 0.05;
Figures 2B,C).
Heart rate obtained during the Langendorff preparation was
also lower in hearts taken from ginseng treated compared to con-
trol rats (1 h control, 313± 16 bpm; 1 h ginseng, 243± 9 bpm; 24 h
control, 308 ± 17 bpm; 24 h ginseng: 248 ± 10 bpm; p < 0.05;
Figure 3B). Similarly, developed pressure and rate of change in
pressure development (+dP/dt and –dP/dt) was reduced in the
ginseng treated compared to the control animals (for developed
force – 1 h control: 88 ± 6 mmHg; 1 h ginseng: 63 ± 5 mmHg;
24 h control, 89± 7mmHg; 24 h ginseng, 61± 5mmHg; p < 0.05;
Figure 3B; for +dP/dt – 1 h control: 3823 ± 186 mmHg/s; 1 h
ginseng: 2740 ± 153 mmHg/s; 24 h control, 3864 ± 201 mmHg/s;
24 h ginseng, 2922 ± 239 mmHg/s; p < 0.05; Figure 3B; and
for –dP/dt −1 h control: 3183 ± 42 mmHg/s; 1 h ginseng:
2266 ± 79 mmHg/s; 24 h control, 3147 ± 35 mmHg/s; 24 h gin-
seng, 2057 ± 210 mmHg/s; p < 0.05; Figure 3B). However there
was no main effect for time (i.e., 1 vs. 24 h) for either any of these
variables. No difference was observed in the baseline coronary per-
fusion pressure in the constant ﬂow perfused heart preparations:
control 50 ± 3 mmHg, 1 h ginseng 49 ± 2 mmHg, 24 h ginseng
51 ± 3 mmHg.
In the subset of rats in which different doses of ginseng were
added to the perfusate following collection of control data (i.e.,
not pre-treated with ginseng), there was a dose-dependent effect
of ginseng on cardiac function. Developed pressure and HR were
decreased in response to both 25 μg/ml (developed pressure was
69 ± 4% and HR was 93 ± 3% of control) and 250 μg/ml (devel-
oped pressure was 58 ± 7% and HR was 78 ± 7% of control),
p < 0.05; Figure 4). For the perfused heart, we also noted that
washout of the test compounds was on occasion accompanied by
decrease in function before recovery of both HR and developed
pressure (by 3–5 min post-washout) was seen. This was likely
due to indirect effects associated with changes in the perfusate.
We extended the whole heart study to examine Ca2+ transients
in single isolated cardiomyocytes. Cells were loaded with the
Table 1 | ECG data from control and 1 and 24 h water ginseng treated rats.
Heart rate (BPM) RR interval (s) PR interval (s) QRS interval (s) QT interval (s)
1 hr control 385 ± 6 0.158 ± 0.003 0.047 ± 0.001 0.015 ± 0.001 0.045 ± 0.003
1 hr ginseng 365 ± 5* 0.165 ± 0.003 * 0.052 ± 0.001* 0.017 ± 0.001* 0.05 ± 0.004*
24 hr control 388 ± 6 0.154 ± 0.004 0.048 ± 0.001 0.015 ± 0.001 0.045 ± 0.002
24 hr ginseng 356 ± 6* 0.169 ± 0.005 * 0.052 ± 0.002* 0.017 ± 0.001* 0.05 ± 0.005*
Data are expressed as mean ± SEM, n = 8 for control and ginseng treated group. *p < 0.05 vs. control. BPM, beats per minute.
FIGURE 2 | Non-invasive measures of blood pressure recorded from
control animals and those treated with water-soluble ginseng extract
(n = 8/group; 1 and 24 h after gavaging). (A) Shows the HR responses.
(B,C) Display systolic and diastolic blood pressure, respectively. Data are
presented as mean ± SE. *p < 0.05 compared to control; #p < 0.05
compared to 1 h ginseng treated.
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FIGURE 3 | Langendorff isolated-perfused heart data recorded from
control and water-soluble ginseng extract treated rats (n = 6/group; 1
and 24 h after gavaging). (A) Shows representative traces of developed
pressure recorded from spontaneous beating hearts of control and ginseng
treated rats. (B) Depicts the HR and developed pressure responses. Data are
presented as mean ± SE. *p < 0.05 compared to control.
Ca2+-sensitive dye fura-2 and monitored by spectrophotometry.
The 345/380 ratio reﬂects Ca2+ concentration.Water-soluble gin-
seng was applied focally by pressure ejection from a micropipette.
Whereas vehicle control had no effect on [Ca2+]i (Figure 5A
at left), treatment with ginseng did cause a decrease in the
[Ca2+]i. Ca2+ transients were progressively decreased in response
to 1 μg/ml 75 ± 4% and 10 μg/ml 31 ± 10% ginseng (p < 0.05;
Figure 5B). In addition to the decrease in the calcium tran-
sients, as shown in Figure 5B, there was a small decline in basal
calcium levels amounting to ratio changes of 0.79 ± 0.06 for
1 μg/ml and 0.76 ± 0.04 for 10 μg/ml, for the periods of ginseng
application.
DISCUSSION
The goal of this study was to determine the effects of North
American, water-soluble ginseng on cardiac contractile function
using both in vivo and ex vivo models. The main ﬁnding was
that acute administration of ginseng resulted in depressed car-
diac contractile function, as evidenced by reductions in HR
and developed pressure, which persisted up to 24 h. This acute
reduction in cardiac contractile function appears to be intrin-
sic to the myocardium, as a direct inhibitory effect of North
American ginseng was observed on spontaneously beating per-
fused hearts exposed to different concentrations of ginseng, and
on intracellular calcium transients in freshly isolated cardiac
myocytes.
HEART RATE RESPONSE
Heart Rate was signiﬁcantly reduced in response to treatment with
ginseng. This held true for each of the different methods used to
measure HR (ECG, ∼6–8% decrease; tail cuff inﬂation, ∼9–13%;
Langendorff preparation, ∼19–22%). This observation is in line
with previous reports showing that, in humans, ginseng admin-
istration resulted in a signiﬁcant reduction in HR (Kiesewetter
et al., 1992; Zheng and Moritani, 2008). It is quite likely that
the negative chronotropic effects of American ginseng occurs at
all levels of the heart, including sinoatrial node, atrioventricular
node conduction and cardiac muscle as ECG intervals reﬂect-
ing these events were all similarly depressed (Figure 1; Table 1).
The depressed HR response observed in the ginseng treated group
might be related to some of the bioactive compounds of ginseng.
The active ingredients of ginseng which lead to the alterations
of heart function are not fully understood. In terms of the
water-soluble North American ginseng utilized in this study, it
contains not only ginsenoside Re (G-Re), but also other ginseno-
sides (Rb1, Re, Rc, Rd, Rg1, and Rb2) which might interact with
each other. Moreover, high-performance liquid chromatography
analysis of the aqueous ginseng extracts has shown that they are
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FIGURE 4 | Effect of direct administration of water-soluble ginseng
extract (25 and 250 μg/ml) on developed pressure and heart rate
of Langendorff isolated-perfused rat hearts (n = 4/group).
(A) Shows the representative traces of developed pressure recorded
from spontaneous beating rat hearts after 25 and 250 μg/ml ginseng
treatments. (B) Displays the percentage change in developed pressure
and HR. Data are presented as mean ± SE. *p < 0.05 compared to
control.
enriched in polysaccharides (Azike et al., 2011). Available studies
have shown that ginseng polysaccharides are active components
and have a number of pharmaceutical activities (including anti-
tumor, antioxidant, and hypoglycemic activities (Konno et al.,
1985; Shin et al., 2004; Luo and Fang, 2008). Unfortunately,
limited information is currently available about the effects of
ginseng polysaccharides on the heart. In contrast, it is clear
that speciﬁc ginsenosides may inﬂuence cardiac function. For
example, G-Re suppresses mechanical alternans recorded from
human and cat atrial myocytes and feline Langendorff-perfused
hearts (Wang et al., 2008). This may be a consequence of an
increased open probablility of sarcoplasmic reticulum (SR) ryan-
odine receptors resulting in reduced SR calcium content (Wang
et al., 2008) an event which could lead to the reduction in internal
calcium of myocytes observed in the present study. The cur-
rent observation of reduced calcium transients (Figure 5) further
suggests that force generation by the ventricular myocytes may
have been compromised upon the addition of ginseng and this
would help explain the reduced developed pressure noted in the
Langendorff preparation (Figures 3 and 4). G-Re has previously
been observed to decrease force and rate of contraction in a dose
dependent manner in an atrial preparation from guinea pigs, pos-
sibly due to blockage of calcium channels (Jin and Liu, 1994; Jin,
1996).
Hence, at this point it is unclear whether differences in proﬁle
or content of ginsenosides or polysaccharides are responsible for
the observed effects on HR. Given these observations, a systematic
examination of the different ginseng components and indeed type
of ginseng (North American vs. Asian) is warranted.
CHANGES IN DEVELOPED PRESSURE
In this study, systemic BP was measured in vivo and developed
pressure of the heart was assessed ex vivo. Although the non-
invasive in vivo measurements suggested no alterations in BP in
response to ginseng administration, the ex vivo responses derived
from the Langendorff isolated-perfused hearts indicated a signif-
icant reduction in the left ventricle developed pressure. Although
these results may appear contradictory, it is important to note
that during the in vivo measurements, the ginseng treated animals
remained under the inﬂuence of neural and humoral regulation.
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FIGURE 5 | Effect of water-soluble ginseng extract (1 and 10 μg/ml) on
intracellular Ca2+ transient changes in rat ventricular myocytes.
(A) Typical experiments showing the effect of direct administration of
vehicle control, 1 and 10 μg/ml ginseng for 30 s on intracellular Ca2+
transients. The fura-2 loaded myocyte was paced at 0.5 Hz (see Materials
and Methods for details). (B) Concentration-dependent response of ginseng
on intracellular Ca2+ transient changes. [Ca2+]i expressed as the
percentage change of control. Data are presented as mean ± SE.
*p < 0.05 compared to control; #p < 0.05 compared to 1 μg/ml ginseng
dose. n = 5 in each group.
This is important because any changes observed during the ex
vivo preparation must be related to intrinsic properties of the
myocardium. The lack of effect of ginseng administration on BP
is a common observation in the live animal (Moey et al., 2012;
Pan et al., 2012) and can possibly be accounted for by compen-
satory mechanisms. Indeed, as cardiac output was not measured
in vivo, the observed maintenance of BP (Figure 1) suggests that
stroke volumemay have been increased, so that cardiac output was
maintained, possibly as a consequence of the Frank-Starlingmech-
anism, enhanced sympathetic drive or a combination of both.
Similarly, enhanced sympathetic drive could lead to peripheral
adaptations in the vasculature which could maintain BP in vivo.
In the absence of these compensatory adaptations in the live ani-
mal, ginseng appears to depress both HR and contractile function
of the isolated heart.
EVIDENCE OF ACUTE REDUCTION IN CARDIAC CONTRACTILE
FUNCTION APPEARS TO BE INTRINSIC TO THE MYOCARDIUM
In order to further examine the direct effect of North American
ginseng on rat cardiac contractile function, spontaneously beat-
ing perfused hearts were examined at varying concentrations of
water-soluble ginseng by using the Langendorff preparation. HR
and developed pressure were signiﬁcantly decreased when ginseng
was administered but the changes in HR and developed pres-
sure were greater as the ginseng concentration was increased from
25 to 250 μg/ml. This suggests not only that administration of
North American ginseng has an effect on the rat cardiac contrac-
tile function, but also that this response might occur in a dose
(concentration)-dependent manner.
To further understand the factors underlying the decrease in
developed pressure of the heart, changes in intracellular Ca2+
were evaluated in isolated myocytes. After direct treatment with
ginseng, decreased intracellular Ca2+ transient changes were
observed using the ﬂuorescent indicator fura-2 in freshly iso-
lated cardiac myocytes. A small decline in basal calcium levels
amounting to ratio changes of 0.79 ± 0.06 for 1 μg/ml and
0.76 ± 0.04 for 10 μg/ml, for the periods of ginseng appli-
cation was also noted. As noted above, previous studies have
shown that the ginsenosides Re and/or Rb1 suppressed intra-
cellular Ca2+ transients in cat, human and rat myocytes (Scott
et al., 2001; Wang et al., 2008); however, the mechanisms reg-
ulating this inhibitory effect of ginsenosides remain to be fully
elucidated. It has been suggested that the inhibitory effect might
be related to blocking both the probability and duration of open-
ing of the plasma membrane L-type Ca2+ channel (Zhang et al.,
1994; Zhong et al., 1995). Alternatively, enhanced opening of
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ryanodine receptors localized at the SR (Wang et al., 2008) or
stimulation of nitric oxide production (Gillis, 1997; Scott et al.,
2001) have been also proposed as potential mechanisms con-
trolling this reduction in intracellular Ca2+. Interestingly, while
these experiments on isolated myocytes may help explain the
decline in developed pressure with the Langendorff prepara-
tion, they cannot account for the HR changes observed in the
in vivo (Figure 1) and ex vivo (Figures 3 and 4) experiments,
as we paced the myocytes and did not speciﬁcally isolate pace-
maker cells. Overall, data from the present study support the
idea that administration of North American ginseng (P. quin-
quefolius) has important effects on cardiac contractile function
and suggest that those effects are the result of changes in intrin-
sic properties of the myocardium, likely associated with calcium
handling.
CONCLUSION
In conclusion, this study did not support the hypothesis that acute
administration of North American ginseng would have no effect
on cardiac function. Rather it demonstrated that acute adminis-
tration depresses cardiac contractile function in the rat as early as
1 h andup to at least 24 h after its administration. This acute reduc-
tion in cardiac contractile function appears to be dose-dependent
and to rely on mechanisms intrinsic to the myocardium.
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